Skip to main content

Animations

MJFF Publications

3921 - 3930 of 6324 Results
Title
Year
  • Year
  • 2021
  • 2015
  • 2018
  • 2023
  • 2024
  • 2020
  • 2015
  • 2021
  • 2021
  • 2016
  • Summary Details
    OPEN
    Title: Genomewide Association Studies of LRRK2 Modifiers of Parkinson's Disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/ana.26094
    Citation Count: 41
  • Summary Details
    OPEN
    Title: KTKEGV repeat motifs are key mediators of normal α-synuclein tetramerization: Their mutation causes excess monomers and neurotoxicity
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.1505953112
    Citation Count: 153
  • Summary Details
    OPEN
    Title: Best Practices for Generating and Using Alpha-Synuclein Pre-Formed Fibrils to Model Parkinson’s Disease in Rodents
    Journal Name: Journal of Parkinson's Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.3233/jpd-171248
    Citation Count: 234
  • Summary Details
    OPEN
    Title: A Fixable Fluorescence‐Quenched Substrate for Quantitation of Lysosomal Glucocerebrosidase Activity in Both Live and Fixed Cells
    Journal Name: Angewandte Chemie International Edition
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/anie.202309306
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Benchmarking of a multi‐biomarker low‐volume panel for Alzheimer's disease and related dementia research
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/alz.14413
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Protein synthesis is suppressed in sporadic and familial Parkinson’s disease by LRRK2
    Journal Name: The FASEB Journal
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1096/fj.202001046r
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Dopaminergic, serotonergic, and noradrenergic deficits in Parkinson disease
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/acn3.246
    Citation Count: 178
  • Summary Details
    OPEN
    Title: Differential cardiopulmonary monitoring system for artifact-canceled physiological tracking of athletes, workers, and COVID-19 patients
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1126/sciadv.abg3092
    Citation Count: 91
  • Summary Details
    OPEN
    Title: Plasma-borne indicators of inflammasome activity in Parkinson’s disease patients
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-020-00147-6
    Citation Count: 67
  • Summary Details
    OPEN
    Title: Widespread transneuronal propagation of α-synucleinopathy triggered in olfactory bulb mimics prodromal Parkinson’s disease
    Journal Name: Journal of Experimental Medicine
    Publisher: Rockefeller University Press
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1084/jem.20160368
    Citation Count: 348
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.